Clinical trials
Hematoma clinical trials
Below are recruiting hematoma clinical trials, each written for real people, not researchers. We’re tracking 65 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07246473Recruiting
Non-invasive ultrasound for brain bleed clearance
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
Wuhu, AnhuiAges 18–80 - NCT07197840Recruiting
Registry for subdural hematoma embolization
This study is a registry for people with a subdural hematoma (a blood collection on the surface of the brain) who are planning to have a procedure to block one of the arteries in the scalp. The registry will track how these patients do over time.
New York, New YorkAges 18–98 - NCT07166302Recruiting
Ultrasound study of bleeding risk after EMG in patients on blood thinners
This study uses ultrasound to check for bleeding after a needle EMG (a test for nerve and muscle problems) in people taking direct oral anticoagulants (blood thinners). It aims to see if it's safe to have the test while on this medication.
Brno, Czech RepublicAges Any age - NCT02201589Recruiting
Endovascular repair for certain ascending aorta problems
This trial studies whether a minimally invasive (endovascular) procedure can safely treat specific serious problems of the ascending aorta. It may help people who are too high-risk for standard open-heart surgery, but only if their anatomy fits and certain risks are ruled out.
Long Beach, CaliforniaAges 18 years+ - NCT06953141Recruiting
Ultrasound to measure blood loss after gynecologic surgery
This trial uses ultrasound to check for hidden internal bleeding after gynecologic surgery. It could help doctors find bleeding earlier and avoid complications.
NazarethAges 18–70 - NCT06658730Recruiting
A study to check long-term safety of a Gore thoracic stent graft
This registry study tracks patients who have or will receive a Gore thoracic stent graft to see how well the device performs over time. It helps doctors understand the device's long-term benefits and any possible complications.
Tucson, ArizonaAges 18 years+ - NCT06504576RecruitingPhase 2
Testing cilostazol to clear brain bleed
This clinical trial tests whether a medication called cilostazol can help the body reabsorb a brain bleed (intracerebral hemorrhage) more quickly. It is for adults with a small bleed in a specific part of the brain (thalamus or basal ganglia) who are otherwise in good health.
Taipei, Not Required For This CountryAges 20–80 - NCT06484374Recruiting
AI-robot guided surgery for large basal ganglia bleeding
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
NanjingAges 18 years+ - NCT06465719Recruiting
Robot-assisted surgery for moderate brain bleeding
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
Hangzhou, ZhejiangAges 18 years+ - NCT04471909Recruiting
Stent graft for aortic arch problems in high-risk patients
This study tests a new stent graft device to treat problems in the aortic arch, such as aneurysms or chronic dissections, without open surgery. It may help people who are not good candidates for traditional open repair.
Birmingham, AlabamaAges 18 years+ - NCT04434807Recruiting
Surgery soon after brain bleed vs standard care
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
Newcastle, New South WalesAges 18 years+ - NCT05794321RecruitingPhase 2
IV tranexamic acid during gender-affirming chest surgery
This Phase 2 study tests whether giving tranexamic acid through a vein during gender-affirming mastectomy can safely reduce bleeding. It may help lower blood loss and related complications during surgery.
San Francisco, CaliforniaAges 18 years+ - NCT05548530Recruiting
Comparing outcomes after brain bleeding from different causes
This study looks at people with bleeding inside the brain to see how different treatment choices are linked to recovery. It may help doctors choose the most effective approach for patients with similar bleeding patterns.
Guiyang, GuizhouAges 18–80 - NCT05374681Recruiting
Test a minimally invasive add-on treatment for brain vessel swelling
This trial studies whether an add-on, minimally invasive procedure works better than standard care for a specific brain blood-vessel problem (CSH) that is larger than 10 mm. It may help reduce symptoms or prevent worsening, if you meet the size and location requirements.
Amiens, FranceAges 18 years+ - NCT04229966Recruiting
Study of real-world treatment for acute epidural bleeding after injury
This observational study looks at how doctors treat an acute epidural hematoma in large head-injury surgeries as they would in routine care. It may help improve understanding of which real-world treatment choices lead to better outcomes.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT03244020Enrolling by invitationPhase 4
Aspirin or low-dose blood thinner after bone or leg surgery
This trial compares aspirin versus a low-dose injectable blood thinner (LMWH) to prevent blood clots after certain orthopedic cancer surgeries. It may help lower the risk of dangerous clotting while balancing bleeding and side effects.
Los Angeles, CaliforniaAges 18 years+ - NCT02346929Recruiting
Hematoma Block for Broken Wrist Pain Relief
This trial studies an injection called a “hematoma block” to numb pain from a broken wrist (distal radius fracture). It may help reduce pain while you’re in the emergency department.
Boston, MassachusettsAges 18–100
Hear when a new Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hematoma?
- Yes. Clin2 currently lists 65 recruiting hematoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hematoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hematoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.